
Corrigendum to “Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23)” [Bioorg. Med. Chem. Lett. 23 (2013) 5361–5366]
Biftu, Tesfaye, Qian, Xiaoxia, Chen, Ping, Feng, Dennis, Scapin, Giovanna, Gao, Ying-Duo, Cox, Jason, Roy, Ranabir Sinha, Eiermann, George, He, Huabing, Lyons, Kathy, Salituro, Gino, Patel, Sangita, PVolume:
24
Langue:
english
Journal:
Bioorganic & Medicinal Chemistry Letters
DOI:
10.1016/j.bmcl.2014.04.007
Date:
June, 2014
Fichier:
PDF, 186 KB
english, 2014